SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-010503
Filing Date
2018-07-26
Accepted
2018-07-26 08:01:42
Documents
65
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 722282
2 ex31-1.htm EX-31.1 17036
3 ex31-2.htm EX-31.2 12857
4 ex32-1.htm EX-32.1 5696
5 ex32-2.htm EX-32.2 5853
  Complete submission text file 0001493152-18-010503.txt   2922885

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vbiv-20180630.xml EX-101.INS 406399
7 XBRL SCHEMA FILE vbiv-20180630.xsd EX-101.SCH 49129
8 XBRL CALCULATION FILE vbiv-20180630_cal.xml EX-101.CAL 56734
9 XBRL DEFINITION FILE vbiv-20180630_def.xml EX-101.DEF 105003
10 XBRL LABEL FILE vbiv-20180630_lab.xml EX-101.LAB 273523
11 XBRL PRESENTATION FILE vbiv-20180630_pre.xml EX-101.PRE 186448
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 18970233
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1